About Bo James

One Response to October FDA Meeting Presentations
  1. Drug Interactions with Hormonal Contraceptives; Public Health and Drug Development Implications; Public Meeting, November 9, 2015, FDA White Oak Campus, 10903 New Hampshire Ave.


[top]

Leave a Reply

Your email address will not be published. Required fields are marked *